CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance

Obesity

Volumn 22, Issue 5, 2014, Pages 1264-1274

  Deiuliis, Jeffrey A ^a   Oghumu, Steve ^b   Duggineni, Dheeraj ^a   Zhong, Jixin ^a   Rutsky, Jessica ^a   Banerjee, Ambar ^b   Needleman, Bradley ^b   Mikami, Dean ^b   Narula, Vimal ^b   Hazey, Jeffrey ^b   Satoskar, Abhay R ^b   Rajagopalan, Sanjay ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12; CXCR3 PROTEIN, HUMAN; CXCR3 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BONE MARROW CELL; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MACROPHAGE ACTIVATION; MALE; MOLECULAR PATHOLOGY; MONOCYTE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOFT TISSUE INFLAMMATION; T LYMPHOCYTE; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; GENE TARGETING; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; LIPID DIET; MACROPHAGE; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MUS;

ADULT; ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; GENE TARGETING; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERFERON-GAMMA; INTRA-ABDOMINAL FAT; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICE, TRANSGENIC; MIDDLE AGED; OBESITY; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION; TRIGLYCERIDES; UP-REGULATION;

EID: 84899905224     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20642     Document Type: Article

References (40)

1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr, AW,. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
2. Wu H, Ghosh S, Perrard XD,et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115: 1029-1038.
3. Kintscher U, Hartge M, Hess K, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosc Thromb Vasc Biol 2008; 28: 1304-1310.
4. Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
5. Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929.
6. Deiuliis J, Shah Z, Shah N, et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One 2011; 6: e16376.
7. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505.
8. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116: 115-124.
9. Groom JR, Luster AD,. CXCR3 in T cell function. Exp Cell Res 2011; 317: 620-631.
10. Hu JK, Kagari T, Clingan JM, Matloubian M,. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. Proc Natl Acad Sci U S A 2011; 108: E118-E127.
11. Lacotte S, Brun S, Muller S, Dumortier H,. CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci 2009; 1173: 310-317.
12. Luster AD, Leder P,. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med 1993; 178: 1057-1065.
13. Luster AD, Greenberg SM, Leder P,., The IP-, 10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182: 219-231.
14. Zhou J, Tang PC, Qin L, et al. CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med 2010; 207: 1951-1966.
15. Zengel P, Nguyen-Hoang A, Schildhammer C, Zantl R, Kahl V, Horn E,. mu-Slide Chemotaxis: a new chamber for long-term chemotaxis studies. BMC Cell Biol 2011; 12: 21.
16. Gutierrez DA, Kennedy A, Orr JS, et al. Aberrant accumulation of undifferentiated myeloid cells in the adipose tissue of CCR2-deficient mice delays improvements in insulin sensitivity. Diabetes 2011; 60: 2820-2829.
17. Morris DL, Oatmen KE, Wang T, DelProposto JL, Lumeng CN,. CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity. Obesity 2012; 20: 1189-1199.
18. Strissel KJ, Stancheva Z, Miyoshi H, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007; 56: 2910-2918.
19. Crane MJ, Hokeness-Antonelli KL, Salazar-Mather TP,. Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J Immunol 2009; 183: 2810-2817.
20. Shi C, Pamer EG,. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011; 11: 762-774.
21. Xiao BG, Ma CG, Xu LY, Link H, Lu CZ. IL-, 12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Mol Immunol 2008; 45: 1191-1196.
22. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-, 12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96-105.
23. Kastelein RA, Hunter CA, Cua DJ,. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25: 221-242.
24. Oliveira MA, Lima GM, Shio MT, Leenen PJ, Abrahamsohn IA,. Immature macrophages derived from mouse bone marrow produce large amounts of IL-12p40 after LPS stimulation. J Leukoc Biol 2003; 74: 857-867.
25. Cancello R, Tordjman J, Poitou C, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006; 55: 1554-1561.
26. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A, Dandona P,. Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia 2007; 50: 278-285.
27. Feng B, Jiao P, Nie Y, et al. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS One 2011; 6: e24358.
28. Tamura Y, Sugimoto M, Murayama T, et al. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arteriosc Thromb Vasc Biol 2008; 28: 2195-2201.
29. Seung E, Cho JL, Sparwasser T, Medoff BD, Luster AD,. Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection. J Immunol 2011; 186: 6830-6838.
30. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-969.
31. Perreault M, Marette A,. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 2001; 7: 1138-1143.
32. Sugita H, Fujimoto M, Yasukawa T, et al. Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem 2005; 280: 14203-14211.
33. Hotamisligil GS, Shargill NS, Spiegelman BM,. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
34. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM,. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543-1549.
35. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME,. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 2008; 16: 1248-1255.
36. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS,. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity 2010; 18: 1918-1925.
37. Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T,. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012; 55: 2583-2592.
38. Vignali DA, Kuchroo VK,. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012; 13: 722-728.
39. Wills-Karp M,. IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 2001; 107: 9-18.
40. Manicone AM, Burkhart KM, Lu B, Clark JG,. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res 2008; 34: 391-407.